﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Silicon Investor - Pain Therapeutics, Inc. (PTIE)</title><copyright>Copyright © 2013 Knight Sac Media.  All rights reserved.</copyright><link>http://www.siliconinvestor.com/subject.aspx?subjectid=56354</link><description>Recently PTIE closed a deal with King Pharmaceuticals on its abuse resistent opioid pain killer, Remoxy, and on 1/4/06 was paid $150 M.  The deal could bring as much as $400 M plus royalties.  PTIE also has Oxytrex, an opioid pain killer that has fewer side effects and fewer withdrawal complications...</description><image><url>http://www.siliconinvestor.com/images/Logo380x132.png</url><title>SI - Pain Therapeutics, Inc. (PTIE)                              </title><link>http://www.siliconinvestor.com/subject.aspx?subjectid=56354</link><width>380</width><height>132</height></image><ttl>10</ttl></channel></rss>